Streetbeat News

Products Services

WKHS

Workhorse Group Inc. (NASDAQ:WKHS) announced an agreement with an institutional investor for financing transactions up to $139M to support its zero emission commercial vehicles roadmap. The deal includes senior secured convertible notes and warrants, with an immediate $9M note and related warrants issued to provide liquidity for operations and redeem existing debt.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 1:05 pm

PTPI

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) has announced the successful launch of an AI tool developed in collaboration with a major software provider, aimed at optimizing self-screening for STENDRA (avanafil), an erectile dysfunction medication in development for OTC status. The AI tool is part of a Human Factors study designed to assess the safety and effectiveness of the web app used for patient self-screening, in line with FDA guidance. The company believes this AI integration will address FDA requests and help achieve significant clinical milestones for STENDRA.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 1:04 pm

FRSX

Foresight Autonomous Holdings Ltd. (FRSX), through its subsidiary Eye-Net Mobile Ltd., has secured an additional order from a leading Japanese vehicle manufacturer for a development project aimed at integrating Eye-Net's V2X communication technology, Eye-Zone™, into the manufacturer's ADAS systems. This follows the successful completion of initial phases of a proof-of-concept project demonstrating the technology's potential benefits for automotive safety and communication.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 12:44 pm

SGBX

Safe & Green Holdings Corp. (NASDAQ:SGBX) and Soldier On, Inc. have announced a non-binding Letter of Intent to design, build, and operate an 800-unit supportive housing community for veterans and first responders with disabilities. The project also includes an 80,000-square-foot, ADA-compliant manufacturing facility in McClean, Oklahoma, aimed at employing wounded veterans in the construction of the housing units.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 12:41 pm

CERS

CRNX

HOTH

Cerus Corporation (CERS) announced its ReCePI Phase 3 trial of INTERCEPT Blood System met its primary efficacy endpoint, with no significant difference in safety endpoints. Crinetics Pharmaceuticals (CRNX) shares rose after its Phase 3 trial of paltusotine in acromegaly met primary and all secondary endpoints. Hoth Therapeutics (HOTH) reported HT-ALZ as a promising solution for Alzheimer's disease-related neuroinflammation and cognitive deficits.

Portfolio Pulse from ryanfaloona@benzinga.com

March 19, 2024 | 12:41 pm

TPET

Trio Petroleum Corp (TPET) has provided an update on its operations in Monterey County, California, announcing the successful production of the HH-1 well at McCool Ranch, producing approximately 47 barrels of oil per day. Additionally, the company plans to restart the 58X and 35X wells at McCool Ranch and the HV-3A well at Presidents Field in the South Salinas Project shortly. This will result in four actively producing oil wells, with plans to restart two more wells in the near future, aiming to generate significant cash flow.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 12:40 pm

KULR

KULR Technology Group Inc. has received an initial order for battery testing of its SafeCASE product from a US automaker. This marks a significant step for KULR in the automotive industry, potentially leading to more extensive collaborations and adoption of its technology in automotive battery safety and testing.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 12:37 pm

PPSI

Pioneer Power Solutions, Inc. (NASDAQ:PPSI) has launched HOMe-Boost, a new residential power generation and EV charging platform. HOMe-Boost offers homeowners reliable prime power with fast Level 2 or Level 3 EV charging options. It allows for flexibility between using the prime generator or the grid, with an easy installation process. The product comes in two versions, L2 and L3, catering to different power needs and providing an off-grid option during extreme weather or natural disasters. Pioneer markets HOMe-Boost through select electrical distributors and generator dealers.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 12:37 pm

ELVN

Enliven Therapeutics announced a $90M private placement financing, with participation from new and existing investors. The net proceeds are expected to extend the company's cash runway into late 2026, supporting key clinical milestones for ELVN-001 and ELVN-002. An event with KOLs is scheduled for April 11, 2024, to discuss Phase 1a trial data of ELVN-001 in adults with chronic myeloid leukemia.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 12:36 pm

ICCM

IceCure Medical announced positive topline results from its ICE3 cryoablation breast cancer study, with 96.39% of patients showing no local recurrence. The company plans to submit the full dataset to the FDA in April for marketing authorization of ProSense® for early-stage breast cancer treatment. This study is the largest of its kind in the U.S. for early-stage low-risk malignant breast tumors, with no significant device-related adverse events reported.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 12:34 pm